in a double-blind study , we randomly assigned 84 patients with chronic lymphocytic leukemia who were judged to be at increased risk of bacterial infection to receive intravenous immunoglobulin g ( 400 mg per kilogram of body weight ) or a placebo every three weeks for one year .
C0023434
chronic
C0085297
intravenous immunoglobulin